Pharsight®, a Certara™ company, is a market-leading provider of software products and scientific consulting services to help pharmaceutical and biotechnology companies improve their drug development process, regulatory compliance and strategic decision-making. Established in 1995, the company's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.
Our management, consulting services and technical staff have a broad range of expertise and experience in key drug development disciplines including clinical pharmacology, drug and disease modeling, biostatistics, strategic decision-making, regulatory strategy, clinical development and information technology.
Headquartered in St. Louis, Missouri, Pharsight has offices in Sunnyvale, California; Cary, North Carolina; Montreal, Canada; Munich, Germany; and staff and business representatives throughout the United States, Europe and Pacific Rim.
Pharsight products and services are used by all of the world’s top 50 pharmaceutical firms, and we have a rapidly growing base of small and mid-sized pharmaceutical and biotechnology customers.